Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Mono Pharmacare Limited

Mono Pharmacare Limited (MONOPHARMA.NS) Stock Overview

Explore Mono Pharmacare Limited’s financial performance, market position, analyst ratings, and future outlook.

MONOPHARMA.NS●NSE
HealthcareMedical - Distribution
₹8.45
₹0.05(0.60%)
Indian Market opens in 21h 53m

Mono Pharmacare Limited (MONOPHARMA.NS)

Meyka AI Score

Z

Key Financials

Market Cap149.3M
P/E RatioN/A
EPS (TTM)$1.75
ROEN/A
Fundamental Analysis

AI Price Forecasts

1 Month$5.73
3 Months$7.38
1 Year Target$0.16

MONOPHARMA.NS Stock Analysis & Investment Overview (NSE)

Our AI-powered analysis of Mono Pharmacare Limited (NSE: MONOPHARMA.NS) gives investors deep insight into how the stock performs on the NSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Mono Pharmacare Limited's NSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of MONOPHARMA.NS on the NSE shows an RSI of 34.44, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.16 for the NSE listing.

Key metrics behind Mono Pharmacare Limited's NSE-traded stock include a P/E ratio of N/A and a market capitalization of 149.3M. Combined with our AI analysis, these give both institutional and retail investors a clear view of MONOPHARMA.NS on the NSE.

Price Performance (NSE: MONOPHARMA.NS)

1-Day Change
0.60%
5-Day Change
5.63%
1-Month Change
-18.75%
3-Month Change
-29.88%
6-Month Change
-35.50%
Year-to-Date (YTD) Change
-44.41%
1-Year Change
-65.37%
3-Year Change
-72.25%
5-Year Change
-72.25%
All-Time (Max) Change
-72.25%

Contact Information

http://www.monopharmacareltd.com
NaN
Krinkal Apartment, Ahmedabad, GU, 380007

Company Facts

1,150 Employees
IPO DateSep 7, 2023
CountryIN
Actively Trading

Frequently Asked Questions